Stockscreener 앱 받기
1.40
2.19%
0.03
전일 마감가:
$1.37
열려 있는:
$1.37
하루 거래량:
17,932
Relative Volume:
0.22
시가총액:
$6.27M
수익:
$35.41M
순이익/손실:
$-8.22M
주가수익비율:
-0.0512
EPS:
-27.3467
순현금흐름:
$-8.01M
1주 성능:
-7.89%
1개월 성능:
-4.11%
6개월 성능:
-31.03%
1년 성능:
-87.04%
1일 변동 폭
$1.35
$1.438
1주일 범위
$1.33
$1.5199
52주 변동 폭
$1.1701
$13.25
엔버릭 바이오 Stock (ENVB) Company Profile
명칭
Enveric Biosciences Inc
전화
(617) 444-8400
주소
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.40 | 6.27M | 35.41M | -8.22M | -8.01M | -27.35 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
엔버릭 바이오 주식(ENVB)의 최신 뉴스
Enveric Biosciences Inc (NASDAQ: ENVB) Share Price, ENVB Stock News, ENVB Share Price & Updates - kalkine.ca
A third U.S. patent allowance covers Enveric compounds that could treat post-traumatic stress disorder - Stock Titan
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference - ca.finance.yahoo.com
Enveric Biosciences Inc. (ENVB) Peer Comparison – Compare with Others - Value Research
ARMISTICE CAPITAL, LLC Acquires Stake in Enveric Biosciences Inc (ENVB) - GuruFocus
Enveric (ENVB) Shares: Advances 6.11% to $1.39 in the Latest Reading; Key Range - vinanet.vn
Enveric (ENVB) Snapshot: Slides 0.74% to $1.34 in the Latest Reading; Technical View: Support at $1.27 and Resistance at $1.41 Frame the Range in Latest TradingFundamental Weighted - vinanet.vn
Enveric (ENVB) Daily Review: Moves 8.78% Lower to $1.35 for the Current Session; Price-Level Context: the Supplied Trading Band Runs From $1.28 to $1.42 in Latest TradingVanna Flow - vinanet.vn
Enveric Biosciences (ENVB) Q2 Results Highlight Challenges Amid Low Valuation Signals - GuruFocus
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - BioSpace
Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com Nigeria
Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com Canada
Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com India
Enveric Biosciences reports $3.0M net loss, $8.3M cash on hand for Q2 2026 - TradingView
Enveric Biosciences (ENVB) posts H1 2026 loss but raises $8.3M cash - Stock Titan
Enveric Biosciences Posts $3.0 Million Second-Quarter Net Loss - Quiver Quantitative
Enveric Biosciences (NASDAQ: ENVB) deepens Q2 loss while pushing EB-003 toward trials - Stock Titan
Enveric Biosciences (ENVB) holders Lind entities report 1.3–1.4% warrant-based stake - Stock Titan
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - Yahoo Finance
Armistice Capital (ENVB) discloses 405,092-share position in Enveric Biosciences - Stock Titan
Enveric Biosciences reports $3.0M net loss, $8.3M cash on hand for Q2 2026 - TradingView
Enveric Biosciences (ENVB) investors disclose 2.93% stake via 111,145-share warrants - Stock Titan
ENVB Q4 2024 Earnings: Net Loss of $57.60 Per Share Massively Misses Consensus EstimateTech Earnings Analysis - vinanet.vn
ENVB Q4 2024 Earnings: Per-Share Loss of -57.6 Overshoots Consensus by 1,946%Management Guidance Update - vinanet.vn
Enveric Biosciences Inc (NASDAQ: ENVB) Share Price, ENVB Stock News, ENVB Share Price & Updates - Kalkine
Enveric Biosciences (ENVB) Slides 7.19% to $1.55 — Stock Approaches Key Support at $1.47Index Put Call - vinanet.vn
Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga
Enveric reports preclinical data on EB-003 drug candidate By Investing.com - Investing.com Canada
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Yahoo! Finance Canada
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Business Wire
Enveric Biosciences (ENVB) Rallies 8.4% to $1.57 — Key Levels to WatchStock Analysis - dars.gov.et
Enveric Biosciences (ENVB) Rallies 8.4% to $1.57 — Key Levels to WatchIceberg Order - dars.gov.et
ENVB Q4 2024 Earnings: Loss Deepens to -57.6 per Share, Yet Stock Climbs 8.43%Weak Earnings Momentum - vinanet.vn
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Investing News Network
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Business Wire
Enveric Biosciences Welcomes FDA's Guidance on Psychedelic Clinical Trials - Intellectia AI
Enveric Biosciences Inc (ENVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.137|Chg%:-0.203 - TradingKey
TradingKey - TradingKey
TradingKey - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.370|Chg%:-0.090 - tradingkey.com
Enveric Biosciences Inc (ENVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enveric Biosciences (ENVB) Slides to $1.29, Testing Key Support at $1.23Positive Gamma - vinanet.vn
Enveric Biosciences Inc (ENVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enveric Biosciences Shares Edge Lower as Support Level ApproachesVolume Profile - vinanet.vn
ENVB Q4 2024 Earnings: Massive EPS Miss Highlights Pre-Revenue Biotech ChallengesEstimate Revision Count - vinanet.vn
ENVB Q4 2024 Earnings: Sharp EPS Miss Triggers Stock DeclinePretax Income Report - vinanet.vn
ENVB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn
ENVB Q4 2024 Earnings: Significant EPS Miss Amid Continued Pipeline DevelopmentQuarterly Financial Update - vinanet.vn
엔버릭 바이오 (ENVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.49%
자본화:
|
볼륨(24시간):